NCT06324240 2026-01-26
Personalized Vaccine Immunotherapy in Combination With Checkpoint Inhibitor for Treatment of Triple Negative Breast Cancer
Emory University
Phase 1 Recruiting
Clinical Trials
4 trialsNCT03546686 2025-10-27
Peri-Operative Immune Checkpoint Inhibition and Cryoablation in Women With Triple-negative Breast Cancer
University of Texas Southwestern Medical Center
Phase 2 Recruiting
NCT06342037 2024-09-19
TONIC-3
The Netherlands Cancer Institute
Phase 2 Recruiting
NCT03815890 2024-05-30
BELLINI
The Netherlands Cancer Institute
Phase 2 Recruiting